Basic Information
Dyve Biosciences has created a breakthrough platform technology that broadly enables transdermal drug delivery. Dyve has advanced clinical programs in gout and melasma, demonstrating the power and potential of this technology.
Dyve Biosciences, Inc.
California,United States of America
15~50 people
January 01, 2014
audra@pascalecommunications.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios